Role of redox signaling in neuroinflammation and neurodegenerative diseases

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Hsieh, Hsi Lung ^a   Yang, Chuen Mao ^b  

^a CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYTOKINE; CYTOSOLIC PHOSPHOLIPASE A2; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE SYNTHASE; PEPTIDE; PEROXIDASE; PROTEIN; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR;

BACTERIAL INFECTION; BRAIN CELL; BRAIN INFECTION; BRAIN INJURY; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM FUNCTION; DEGENERATIVE DISEASE; ENCEPHALITIS; GENE TARGETING; GLIA CELL; HUMAN; INTRACELLULAR SIGNALING; MEDIATOR RELEASE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PEROXIDATION; PROTEIN EXPRESSION; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; TRANSACTIVATION; BIOSYNTHESIS; BRAIN; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; SIGNAL TRANSDUCTION;

BRAIN; CENTRAL NERVOUS SYSTEM; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84896087394     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/484613     Document Type: Review

References (175)

1. Rahman I., Marwick J., Kirkham P., Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF- B and pro-inflammatory gene expression. Biochemical Pharmacology 2004 68 6 1255 1267 2-s2.0-4143070452 10.1016/j.bcp.2004.05.042 (Pubitemid 39094292)
2. Valko M., Leibfritz D., Moncol J., Cronin M. T. D., Mazur M., Telser J., Free radicals and antioxidants in normal physiological functions and human disease. International Journal of Biochemistry and Cell Biology 2007 39 1 44 84 2-s2.0-33749986298 10.1016/j.biocel.2006.07.001 (Pubitemid 44566469)
3. Lee I. T., Yang C. M., Role of NADPH oxidase/ROS in pro-inflammatory mediators-induced airway and pulmonary diseases. Biochemical Pharmacology 2012 84 5 581 590 10.1016/j.bcp.2012.05.005
4. Dröge W., Free radicals in the physiological control of cell function. Physiological Reviews 2002 82 1 47 95 2-s2.0-0036086130 (Pubitemid 34654215)
5. von Bernhardi R., Eugenín J., Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms. Antioxidants and Redox Signaling 2012 16 9 974 1031 2-s2.0-84857977037 10.1089/ars.2011.4082
6. Halliwell B., Oxidative stress and neurodegeneration: where are we now? Journal of Neurochemistry 2006 97 6 1634 1658 2-s2.0-33745013111 10.1111/j.1471-4159.2006.03907.x (Pubitemid 43873658)
7. Uttara B., Singh A. V., Zamboni P., Mahajan R. T., Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Current Neuropharmacology 2009 7 1 65 74 2-s2.0-65949121134 10.2174/157015909787602823
8. Melo A., Monteiro L., Lima R. M. F., de Oliveira D. M., de Cerqueira M. D., El-Bachá R. S., Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives. Oxidative Medicine and Cellular Longevity 2011 2011 14 2-s2.0-84855584833 10.1155/2011/467180 467180
9. Chiurchiù V., MacCarrone M., Chronic inflammatory disorders and their redox control: from molecular mechanisms to therapeutic opportunities. Antioxidants and Redox Signaling 2011 15 9 2605 2641 2-s2.0-80053004011 10.1089/ars.2010.3547
10. Farfara D., Lifshitz V., Frenkel D., Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease: Alzheimer's review series. Journal of Cellular and Molecular Medicine 2008 12 3 762 780 2-s2.0-44149083565 10.1111/j.1582-4934.2008.00314.x (Pubitemid 351718063)
11. Fuller S., Steele M., Münch G., Activated astroglia during chronic inflammation in Alzheimer's disease-Do they neglect their neurosupportive roles? Mutation Research 2010 690 1-2 40 49 2-s2.0-77955281765 10.1016/j.mrfmmm.2009. 08.016
12. Kimelberg H. K., Receptors on astrocytes-what possible functions? Neurochemistry International 1995 26 1 27 40 2-s2.0-0028851395 10.1016/0197-0186(94)00118-E
13. Eng L. F., Ghirnikar R. S., GFAP and astrogliosis. Brain Pathology 1994 4 3 229 237 2-s2.0-0027931125 (Pubitemid 24261929)
14. Kim Y. S., Joh T. H., Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease. Experimental and Molecular Medicine 2006 38 4 333 347 2-s2.0-33748447845
15. Eddelston M., Mucke L., Molecular profile of reactive astrocytes-implications for their role in neurologic disease. Neuroscience 1993 54 1 15 36 2-s2.0-0027314268 10.1016/0306-4522(93)90380-X (Pubitemid 23147085)
16. Ridet J. L., Malhotra S. K., Privat A., Gage F. H., Reactive astrocytes: cellular and molecular cues to biological function. Trends in Neurosciences 1997 20 12 570 577 2-s2.0-0030697366 10.1016/S0166-2236(97)01139-9 (Pubitemid 27508969)
17. Brown G. C., Mechanisms of inflammatory neurodegeneration: INOS and NADPH oxidase. Biochemical Society Transactions 2007 35 5 1119 1121 2-s2.0-36749005178 10.1042/BST0351119 (Pubitemid 350206442)
18. Koistinaho M., Kettunen M. I., Goldsteins G., Keinänen R., Salminen A., Ort M., Bures J., Liu D., Kauppinen R. A., Higgins L. S., Koistinaho J., β -amyloid precursor protein transgenic mice that harbor diffuse A β deposits but do not form plaques show increased ischemic vulnerability: role of inflammation. Proceedings of the National Academy of Sciences of the United States of America 2002 99 3 1610 1615 2-s2.0-0037022288 10.1073/pnas.032670899 (Pubitemid 34136540)
19. Savage M. J., Lin Y.-G., Ciallella J. R., Flood D. G., Scott R. W., Activation of c-Jun N-Terminal Kinase and p38 in an Alzheimer's Disease Model Is Associated with Amyloid Deposition. The Journal of Neuroscience 2002 22 9 3376 3385 2-s2.0-0036580703 (Pubitemid 37465743)
20. Mrak R. E., Sheng J. G., Griffin W. S. T., Glial cytokines in Alzheimer's disease: review and pathogenic implications. Human Pathology 1995 26 8 816 823 2-s2.0-0029161781
21. Wu C.-Y., Hsieh H.-L., Sun C.-C., Tseng C.-P., Yang C.-M., IL-1 β induces proMMP-9 expression via c-Src-dependent PDGFR/PI3K/Akt/p300 cascade in rat brain astrocytes. Journal of Neurochemistry 2008 105 4 1499 1512 2-s2.0-42549152437 10.1111/j.1471-4159.2008.05318.x (Pubitemid 351590815)
22. Hsieh H.-L., Wu C.-Y., Yang C.-M., Bradykinin induces matrix metalloproteinase-9 expression and cell migration through a PKC- δ -dependent ERK/Elk-1 pathway in astrocytes. Glia 2008 56 6 619 632 2-s2.0-45549092958 10.1002/glia.20637
23. Hsieh H.-L., Wu C.-Y., Hwang T.-L., Yen M.-H., Parker P., Yang C.-M., BK-induced cytosolic phospholipase A2 expression via sequential PKC- δ p42/p44 MARK, and NF- B activation in rat brain astrocytes. Journal of Cellular Physiology 2006 206 1 246 254 2-s2.0-28444434774 10.1002/jcp.20457 (Pubitemid 41740738)
24. Hsieh H.-L., Wang H.-H., Wu C.-Y., Jou M.-J., Yen M.-H., Parker P., Yang C.-M., BK-induced COX-2 expression via PKC- δ -dependent activation of p42/p44 MAPK and NF- B in astrocytes. Cellular Signalling 2007 19 2 330 340 2-s2.0-33845696273 10.1016/j.cellsig.2006.07.006 (Pubitemid 44969982)
25. Lin C. C., Hsieh H. L., Shih R. H., NADPH oxidase 2-derived reactive oxygen species signal contributes to bradykinin-induced matrix metalloproteinase-9 expression and cell migration in brain astrocytes. Cell Communication and Signaling 2012 10 1 35
26. Wang H.-H., Hsieh H.-L., Yang C.-M., Nitric oxide production by endothelin-1 enhances astrocytic migration via the tyrosine nitration of matrix metalloproteinase-9. Journal of Cellular Physiology 2011 226 9 2244 2256 2-s2.0-79958701063 10.1002/jcp.22560
27. Hsieh H. L., Lin C. C., Shih R. H., Hsiao L. D., Yang C. M., NADPH oxidase-mediated redox signal contributes to lipoteichoic acid-induced MMP-9 upregulation in brain astrocytes. Journal of Neuroinflammation 2012 9 110 10.1186/1742-2094-9-110
28. Tung W.-H., Tsai H.-W., Lee I.-T., Hsieh H.-L., Chen W.-J., Chen Y.-L., Yang C.-M., Japanese encephalitis virus induces matrix metalloproteinase-9 in rat brain astrocytes via NF- Κ B signalling dependent on MAPKs and reactive oxygen species. British Journal of Pharmacology 2010 161 7 1566 1583 2-s2.0-78149371023 10.1111/j.1476-5381.2010.00982.x
29. Wang H.-H., Hsieh H.-L., Wu C.-Y., Sun C.-C., Yang C.-M., Oxidized low-density lipoprotein induces matrix metalloproteinase-9 expression via a p42/p44 and JNK-dependent AP-1 pathway in brain astrocytes. Glia 2009 57 1 24 38 2-s2.0-61449218138 10.1002/glia.20732
30. Yang C. M., Hsieh H. L., Lin C. C., Multiple factors from bradykinin-challenged astrocytes contribute to the neuronal apoptosis: involvement of astroglial ROS, MMP-9, and HO-1/CO system. Molecular Neurobiology 2013 47 3 1020 1033 10.1007/s12035-013-8402-1
31. Chrissobolis S., Faraci F. M., The role of oxidative stress and NADPH oxidase in cerebrovascular disease. Trends in Molecular Medicine 2008 14 11 495 502 2-s2.0-54449093276 10.1016/j.molmed.2008.09.003
32. Shi Q., Gibson G. E., Oxidative stress and transcriptional regulation in Alzheimer disease. Alzheimer Disease and Associated Disorders 2007 21 4 276 291 2-s2.0-37349049243 10.1097/WAD.0b013e31815721c3 (Pubitemid 350307432)
33. Demchenko I. T., Oury T. D., Crapo J. D., Piantadosi C. A., Regulation of the brain's vascular responses to oxygen. Circulation Research 2002 91 11 1031 1037 2-s2.0-0037195723 10.1161/01.RES.0000043500.03647.81 (Pubitemid 35416640)
34. Chan P. H., Reactive oxygen radicals in signaling and damage in the ischemic brain. Journal of Cerebral Blood Flow and Metabolism 2001 21 1 2 14 2-s2.0-0035149749 (Pubitemid 32036708)
35. Serrano F., Klann E., Reactive oxygen species and synaptic plasticity in the aging hippocampus. Ageing Research Reviews 2004 3 4 431 443 2-s2.0-8444227821 10.1016/j.arr.2004.05.002 (Pubitemid 39487899)
36. Kamata H., Hirata H., Redox regulation of cellular signalling. Cellular Signalling 1999 11 1 1 14 2-s2.0-0032889677 10.1016/S0898-6568(98)00037-0 (Pubitemid 28546635)
37. Federico A., Cardaioli E., da Pozzo P., Formichi P., Gallus G. N., Radi E., Mitochondria, oxidative stress and neurodegeneration. Journal of the Neurological Sciences 2012 322 1-2 254 262
38. Kang J., Park E. J., Jou I., Kim J.-H., Joe E.-H., Reactive oxygen species mediate A β (25-35)-induced activation of BV-2 microglia. NeuroReport 2001 12 7 1449 1452 2-s2.0-0035947265 (Pubitemid 32476145)
39. Qin L., Liu Y., Wang T., Wei S.-J., Block M. L., Wilson B., Liu B., Hong J.-S., NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. The Journal of Biological Chemistry 2004 279 2 1415 1421 2-s2.0-0346463000 10.1074/jbc. M307657200 (Pubitemid 38082669)
40. Hsieh H.-L., Wang H.-H., Wu W.-B., Chu P.-J., Yang C.-M., Transforming growth factor- β 1 induces matrix metalloproteinase-9 and cell migration in astrocytes: roles of ROS-dependent ERK- and JNK-NF- B pathways. Journal of Neuroinflammation 2010 7, article 88 2-s2.0-78649716241 10.1186/1742-2094-7-88
41. McGeer P. L., McGeer E. G., The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Research Reviews 1995 21 2 195 218 2-s2.0-0029610011 10.1016/0165-0173(95) 00011-9 (Pubitemid 26061873)
42. Rosenberg G. A., Matrix metalloproteinases in neuroinflammation. Glia 2002 39 3 279 291 2-s2.0-0036737795 10.1002/glia.10108
43. Fillit H., Ding W., Buee L., Kalman J., Altstiel L., Lawlor B., Wolf-Klein G., Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neuroscience Letters 1991 129 2 318 320 2-s2.0-0025807206 10.1016/0304-3940(91)90490-K
44. Allan S. M., Tyrrell P. J., Rothwell N. J., Interleukin-1 and neuronal injury. Nature Reviews Immunology 2005 5 8 629 640 2-s2.0-23444441962 10.1038/nri1664 (Pubitemid 41113194)
45. Fassbender K., Rossol S., Kammer T., Daffertshofer M., Wirth S., Dollman M., Hennerici M., Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. Journal of the Neurological Sciences 1994 122 2 135 139 2-s2.0-0028220499 10.1016/0022-510X(94)90289-5 (Pubitemid 24097260)
46. Smith J. A., Das A., Ray S. K., Banik N. L., Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Research Bulletin 2012 87 1 10 20 2-s2.0-84155162481 10.1016/j.brainresbull.2011.10.004
47. Siwik D. A., Colucci W. S., Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium. Heart Failure Reviews 2004 9 1 43 51 2-s2.0-1042303637 10.1023/B:HREV.0000011393.40674.13 (Pubitemid 38196076)
48. Thornton P., Pinteaux E., Gibson R. M., Allan S. M., Rothwell N. J., Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release. Journal of Neurochemistry 2006 98 1 258 266 2-s2.0-33745096234 10.1111/j.1471-4159.2006.03872.x (Pubitemid 43882950)
49. Greig N. H., Mattson M. P., Perry T., Chan S. L., Giordano T., Sambamurti K., Rogers J. T., Ovadia H., Lahiri D. K., New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF- α inhibitors, and GLP-1 receptor agonists. Annals of the New York Academy of Sciences 2004 1035 290 315 2-s2.0-14944371918 10.1196/annals.1332.018 (Pubitemid 40362340)
50. Butterfield D. A., Drake J., Pocernich C., Castegna A., Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β -peptide. Trends in Molecular Medicine 2001 7 12 548 554 2-s2.0-0035194145 10.1016/S1471-4914(01)02173-6 (Pubitemid 33127140)
51. Caspersen C., Wang N., Yao J., Sosunov A., Chen X., Lustbader J. W., Xu H. W., Stern D., McKhann G., Yan S. D., Mitochondrial A β: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. The FASEB Journal 2005 19 14 2040 2041 2-s2.0-28744449206 10.1096/fj.05-3735fje (Pubitemid 41759758)
52. 2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease. The Journal of Biological Chemistry 1999 274 22 15493 15499 2-s2.0-0032983334 10.1074/jbc.274.22.15493 (Pubitemid 29254916)
53. Lim G. P., Chu T., Yang F., Beech W., Frautschy S. A., Cole G. M., The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. The Journal of Neuroscience 2001 21 21 8370 8377 2-s2.0-0035503597 (Pubitemid 33051435)
54. Ding Q., Dimayuga E., Keller J. N., Oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease. Current Alzheimer Research 2007 4 1 73 79 2-s2.0-33847192092 10.2174/156720507779939788
55. Schipper H. M., Bennett D. A., Liberman A., Bienias J. L., Schneider J. A., Kelly J., Arvanitakis Z., Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiology of Aging 2006 27 2 252 261 2-s2.0-29844450760 10.1016/j.neurobiolaging.2005.01.016 (Pubitemid 43038549)
56. Kamiya T., Katayama Y., Kashiwagi F., Terashi A., The role of bradykinin in mediating ischemic brain edema in rats. Stroke 1993 24 4 571 576 2-s2.0-0027458015 (Pubitemid 23100745)
57. Verkhratsky A., Orkand R. K., Kettenmann H., Glial calcium: homeostasis and signaling function. Physiological Reviews 1998 78 1 99 141 2-s2.0-0031893563 (Pubitemid 28070976)
58. Regoli D., Rhaleb N.-E., Dion S., Drapeau G., New selective bradykinin receptor antagonists and bradykinin B2 receptor characterization. Trends in Pharmacological Sciences 1990 11 4 156 161 2-s2.0-0025239942 (Pubitemid 20118009)
59. Bhoola K. D., Figueroa C. D., Worthy K., Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacological Reviews 1992 44 1 1 80 2-s2.0-0026556434
60. Lin C.-W., Shen S.-C., Chien C.-C., Yang L.-Y., Shia L.-T., Chen Y.-C., 12-O-tetradecanoylphorbol-13-acetate-induced invasion/migration of glioblastoma cells through activating PKC α /ERK/NF- B-dependent MMP-9 expression. Journal of Cellular Physiology 2010 225 2 472 481 2-s2.0-77956501267 10.1002/jcp.22226
61. Abramov A. Y., Jacobson J., Wientjes F., Hothersall J., Canevari L., Duchen M. R., Expression and modulation of an NADPH oxidase in mammalian astrocytes. The Journal of Neuroscience 2005 25 40 9176 9184 2-s2.0-27144531055 10.1523/JNEUROSCI.1632-05.2005 (Pubitemid 41500826)
62. Hsieh H.-L., Wang H.-H., Wu C.-Y., Yang C.-M., Reactive oxygen species-dependent c-fos/activator protein 1 induction upregulates heme oxygenase-1 expression by bradykinin in brain astrocytes. Antioxidants and Redox Signaling 2010 13 12 1829 1844 2-s2.0-78149294702 10.1089/ars.2009.2957
63. Levin E. R., Endothelins. The New England Journal of Medicine 1995 333 6 356 363 2-s2.0-0029116310 10.1056/NEJM199508103330607
64. Schinelli S., Pharmacology and physiopathology of the brain endothelin system: an overview. Current Medicinal Chemistry 2006 13 6 627 638 2-s2.0-33645960685 10.2174/092986706776055652
65. Böhm F., Pernow J., The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovascular Research 2007 76 1 8 18 2-s2.0-34548415037 10.1016/j.cardiores.2007.06.004 (Pubitemid 47362047)
66. Hasselblatt M., Lewczuk P., Löffler B.-M., Kamrowski-Kruck H., Von Ahsen N., Sirén A.-L., Ehrenreich H., Role of the astrocytic ETB receptor in the regulation of extracellular endothelin-1 during hypoxia. Glia 2001 34 1 18 26 2-s2.0-0035052933 10.1002/glia.1036 (Pubitemid 32329028)
67. Rogers S. D., Peters C. M., Pomonis J. D., Hagiwara H., Ghilardi J. R., Mantyh P. W., Endothelin B receptors are expressed by astrocytes and regulate astrocyte hypertrophy in the normal and injured CNS. Glia 2003 41 2 180 190 2-s2.0-0037440416 10.1002/glia.10173 (Pubitemid 36262195)
68. Lo A. C. Y., Chen A. Y. S., Hung V. K. L., Yaw L. P., Fung M. K. L., Ho M. C. Y., Tsang M. C. S., Chung S. S. M., Chung S. K., Endothelin-1 overexpression leads to further water accumulation and brain edema after middle cerebral artery occlusion via aquaporin 4 expression in astrocytic end-feet. Journal of Cerebral Blood Flow and Metabolism 2005 25 8 998 1011 2-s2.0-23044459474 10.1038/sj.jcbfm.9600108 (Pubitemid 41061715)
69. Didier N., Romero I. A., Créminon C., Wijkhuisen A., Grassi J., Mabondzo A., Secretion of interleukin-1 β by astrocytes mediates endothelin-1 and tumour necrosis factor- α effects on human brain microvascular endothelial cell permeability. Journal of Neurochemistry 2003 86 1 246 254 2-s2.0-0037971138 10.1046/j.1471-4159.2003.01829.x (Pubitemid 36753865)
70. Lee S. J., Lee S., Toll-like receptors and inflammation in the CNS. Current Drug Targets Inflammation & Allergy 2002 1 2 181 191 2-s2.0-0142155221
71. Kim S.-Y., Lee J.-G., Cho W.-S., Cho K.-H., Sakong J., Kim J.-R., Chin B.-R., Baek S.-H., Role of NADPH oxidase-2 in lipopolysaccharide-induced matrix metalloproteinase expression and cell migration. Immunology and Cell Biology 2010 88 2 197 204 2-s2.0-77149121412 10.1038/icb.2009.87
72. Konat G. W., Kielian T., Marriott I., The role of Toll-like receptors in CNS response to microbial challenge. Journal of Neurochemistry 2006 99 1 1 12 2-s2.0-33748696772 10.1111/j.1471-4159.2006.04076.x (Pubitemid 44395125)
73. Sutcliffe I. C., Shaw N., Atypical lipoteichoic acids of gram-positive bacteria. Journal of Bacteriology 1991 173 22 7065 7069 2-s2.0-0025719032
74. Sáez-Llorens X., McCracken G. H. Jr., Bacterial meningitis in children. The Lancet 2003 361 9375 2139 2148 2-s2.0-0037862949 10.1016/S0140-6736(03)13693-8 (Pubitemid 36782263)
75. Mullaly S. C., Kubes P., The role of TLR2 in vivo following challenge with Staphylococcus aureus and prototypic ligands. The Journal of Immunology 2006 177 11 8154 8163 2-s2.0-33751555738 (Pubitemid 44846335)
76. Mitchell J. A., Paul-Clark M. J., Clarke G. W., McMaster S. K., Cartwright N., Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease. Journal of Endocrinology 2007 193 3 323 330 2-s2.0-34447107898 10.1677/JOE-07-0067 (Pubitemid 47028685)
77. Kinsner A., Pilotto V., Deininger S., Brown G. C., Coecke S., Hartung T., Bal-Price A., Inflammatory neurodegeneration induced by lipoteichoic acid from Staphylococcus aureus is mediated by glia activation, nitrosative and oxidative stress, and caspase activation. Journal of Neurochemistry 2005 95 4 1132 1143 2-s2.0-28244472094 10.1111/j.1471-4159.2005.03422.x (Pubitemid 41713496)
78. Lehnardt S., Henneke P., Lien E., Kasper D. L., Volpe J. J., Bechmann I., Nitsch R., Weber J. R., Golenbock D. T., Vartanian T., A mechanism for neurodegeneration induced by group B Streptococci through activation of the TLR2/MyD88 pathway in microglia. The Journal of Immunology 2006 177 1 583 592 2-s2.0-33745292215 (Pubitemid 43939172)
79. Carpentier P. A., Duncan D. S., Miller S. D., Glial toll-like receptor signaling in central nervous system infection and autoimmunity. Brain, Behavior, and Immunity 2008 22 2 140 147 2-s2.0-37349032870 10.1016/j.bbi.2007.08.011 (Pubitemid 350299811)
80. Bsibsi M., Bajramovic J. J., van Duijvenvoorden E., Persoon C., Ravid R., van Noort J. M., Vogt M. H. J., Identification of soluble CD14 as an endogenous agonist for toll-like receptor 2 on human astrocytes by genome-scale functional screening of glial cell derived proteins. Glia 2007 55 5 473 482 2-s2.0-33847707328 10.1002/glia.20473 (Pubitemid 46383177)
81. Jack C. S., Arbour N., Manusow J., Montgrain V., Blain M., McCrea E., Shapiro A., Antel J. P., TLR signaling tailors innate immune responses in human microglia and astrocytes. The Journal of Immunology 2005 175 7 4320 4330 2-s2.0-25444498280 (Pubitemid 41361966)
82. Neher J. J., Brown G. C., Neurodegeneration in models of Gram-positive bacterial infections of the central nervous system. Biochemical Society Transactions 2007 35 5 1166 1167 2-s2.0-36749024092 10.1042/BST0351166 (Pubitemid 350206452)
83. Chatterjee P. K., Zacharowski K., Cuzzocrea S., Brown P. A. J., Stewart K. N., Mota-Filipe H., Thiemermann C., Lipoteichoic acid from Staphylococcus aureus reduces renal ischemia/reperfusion injury. Kidney International 2002 62 4 1249 1263 2-s2.0-0036380998 10.1046/j.1523-1755.2002.00580.x
84. Palacios G., Oberste M. S., Enteroviruses as agents of emerging infectious diseases. Journal of NeuroVirology 2005 11 5 424 433 2-s2.0-30344474945 10.1080/13550280591002531 (Pubitemid 43064681)
85. McMinn P. C., An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiology Reviews 2002 26 1 91 107 2-s2.0-0036242282 10.1016/S0168-6445(02)00070-0 (Pubitemid 34454778)
86. Huang C.-C., Liu C.-C., Chang Y.-C., Chen C.-Y., Wang S.-T., Yeh T.-F., Neurologic complications in children with enterovirus 71 infection. The New England Journal of Medicine 1999 341 13 936 942 2-s2.0-0033598405 10.1056/NEJM199909233411302 (Pubitemid 29441547)
87. Ho M., Chen E.-R., Hsu K.-H., Twu S.-J., Chen K.-T., Tsai S.-F., Wang J.-R., Shih S.-R., An epidemic of enterovirus 71 infection in Taiwan. The New England Journal of Medicine 1999 341 13 929 935 2-s2.0-0033598371 10.1056/NEJM199909233411301 (Pubitemid 29441546)
88. Tung W.-H., Hsieh H.-L., Lee I.-T., Yang C.-M., Enterovirus 71 induces integrin β 1/EGFR-Rac1-dependent oxidative stress in SK-N-SH cells: role of HO-1/CO in viral replication. Journal of Cellular Physiology 2011 226 12 3316 3329 2-s2.0-80053166668 10.1002/jcp.22677
89. Misra U. K., Kalita J., Overview: Japanese encephalitis. Progress in Neurobiology 2010 91 2 108 120 2-s2.0-77952293291 10.1016/j.pneurobio.2010.01. 008
90. Raung S.-L., Chen S.-Y., Liao S.-L., Chen J.-H., Chen C.-J., Tyrosine kinase inhibitors attenuate Japanese encephalitis virus-induced neurotoxicity. Biochemical and Biophysical Research Communications 2005 327 2 399 406 2-s2.0-11144320637 10.1016/j.bbrc.2004.12.034 (Pubitemid 40040490)
91. Mishra M. K., Koli P., Bhowmick S., Basu A., Neuroprotection conferred by astrocytes is insufficient to protect animals from succumbing to Japanese encephalitis. Neurochemistry International 2007 50 5 764 773 2-s2.0-33947410341 10.1016/j.neuint.2007.01.014 (Pubitemid 46452845)
92. Montine T. J., Montine K. S., Swift L. L., Central nervous system lipoproteins in Alzheimer's disease. American Journal of Pathology 1997 151 6 1571 1575 2-s2.0-0030723754 (Pubitemid 27527920)
93. Keller J. N., Hanni K. B., Markesbery W. R., Oxidized low-density lipoprotein induces neuronal death: implications for calcium, reactive oxygen species, and caspases. Journal of Neurochemistry 1999 72 6 2601 2609 2-s2.0-0033051325 10.1046/j.1471-4159.1999.0722601.x (Pubitemid 29242213)
94. Shie F.-S., Neely M. D., Maezawa I., Wu H., Olson S. J., Jürgens G., Montine K. S., Montine T. J., Oxidized low-density lipoprotein is present in astrocytes surrounding cerebral infarcts and stimulates astrocyte interleukin-6 secretion. American Journal of Pathology 2004 164 4 1173 1181 2-s2.0-1642417467 (Pubitemid 38387784)
95. Uno M., Harada M., Takimoto O., Kitazato K. T., Suzue A., Yoneda K., Morita N., Itabe H., Nagahiro S., Elevation of plasma oxidized LDL in acute stroke patients is associated with ischemic lesions depicted by DWI and predictive of infarct enlargement. Neurological Research 2005 27 1 94 102 2-s2.0-13244258405 10.1179/016164105X18395 (Pubitemid 40189613)
96. Wang H.-H., Hsieh H.-L., Wu C.-Y., Yang C.-M., Oxidized low-density lipoprotein-induced matrix metalloproteinase-9 expression via PKC- δ /p42/p44 MAPK/Elk-1 cascade in brain astrocytes. Neurotoxicity Research 2010 17 1 50 65 2-s2.0-77449123600 10.1007/s12640-009-9077-2
97. Ten Dijke P., Hill C. S., New insights into TGF- β -Smad signalling. Trends in Biochemical Sciences 2004 29 5 265 273 2-s2.0-2342488852 10.1016/j.tibs.2004.03.008 (Pubitemid 38591321)
98. Massagué J., How cells read TGF- β signals. Nature Reviews Molecular Cell Biology 2000 1 3 169 178 2-s2.0-0034574298
99. Leivonen S.-K., Chantry A., Häkkinen L., Han J., Kähäri V.-M., Smad3 mediates transforming growth factor- β -induced collagenase-3 (matrix metalloproteinase-13) expression in human gingival fibroblasts: evidence for cross-talk between Smad3 and p38 signaling pathways. The Journal of Biological Chemistry 2002 277 48 46338 46346 2-s2.0-2242476591 10.1074/jbc.M206535200 (Pubitemid 35417628)
100. Koli K., Myllärniemi M., Keski-Oja J., Kinnula V. L., Transforming growth factor- β activation in the lung: focus on fibrosis and reactive oxygen species. Antioxidants and Redox Signaling 2008 10 2 333 342 2-s2.0-37549027570 10.1089/ars.2007.1914
101. Zipp F., Aktas O., The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases. Trends in Neurosciences 2006 29 9 518 527 2-s2.0-33747890559 10.1016/j.tins.2006.07.006 (Pubitemid 44291819)
102. Vezzani A., Granata T., Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 2005 46 11 1724 1743 2-s2.0-33644625777 10.1111/j.1528-1167.2005.00298.x (Pubitemid 44921957)
103. Simi A., Tsakiri N., Wang P., Rothwell N. J., Interleukin-1 and inflammatory neurodegeneration. Biochemical Society Transactions 2007 35 5 1122 1126 2-s2.0-36749012006 10.1042/BST0351122 (Pubitemid 350206443)
104. Yong V. W., Krekoski C. A., Forsyth P. A., Bell R., Edwards D. R., Matrix metalloproteinases and diseases of the CNS. Trends in Neurosciences 1998 21 2 75 80 2-s2.0-0031989284
105. Yong V. W., Power C., Forsyth P., Edwards D. R., Metalloproteinases in biology and pathology of the nervous system. Nature Reviews Neuroscience 2001 2 7 502 511 2-s2.0-0035405886 10.1038/35081571 (Pubitemid 33676585)
106. Gottschall P. E., Yu X., Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. Journal of Neurochemistry 1995 64 4 1513 1520 2-s2.0-0028934085
107. Lee W. J., Shin C. Y., Yoo B. K., Ryu J. R., Choi E. Y., Cheong J. H., Ryu J. H., Ko K. H., Induction of matrix metalloproteinase-9 (MMP-9) in lipopolysaccharide-stimulated primary astrocytes is mediated by extracellular signal-regulated protein kinase 1/2 (Erk1/2). Glia 2003 41 1 15 24 2-s2.0-0037259961 10.1002/glia.10131 (Pubitemid 36164281)
108. Hernández M., Nieto M. L., Sánchez Crespo M., Cytosolic phospholipase A2 and the distinct transcriptional programs of astrocytoma cells. Trends in Neurosciences 2000 23 6 259 264 2-s2.0-0034195203 10.1016/S0166-2236(00)01563-0 (Pubitemid 30331112)
109. 2 enzymes. Prostaglandins and Other Lipid Mediators 2002 68-69 3 58 2-s2.0-0036669210 10.1016/S0090-6980(02)00020-5 (Pubitemid 35251864)
110. Park J. Y., Pillinger M. H., Abramson S. B., Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clinical Immunology 2006 119 3 229 240 2-s2.0-33745266737 10.1080/10407780600602374
111. Xu J., Chalimoniuk M., Shu Y., Simonyi A., Sun A. Y., Gonzalez F. A., Weisman G. A., Wood W. G., Sun G. Y., Prostaglandin E2 production in astrocytes: regulation by cytokines, extracellular ATP, and oxidative agents. Prostaglandins Leukotrienes and Essential Fatty Acids 2003 69 6 437 448 2-s2.0-0345304316 10.1016/j.plefa.2003.08.016 (Pubitemid 37464054)
112. Leslie C. C., Properties and regulation of cytosolic phospholipase A2. The Journal of Biological Chemistry 1997 272 27 16709 16712 2-s2.0-0030836586 10.1074/jbc.272.27.16709 (Pubitemid 27289760)
113. Sun G. Y., Xu J., Jensen M. D., Yu S., Wood W. G., González F. A., Simonyi A., Sun A. Y., Weisman G. A., Phospholipase A2 in astrocytes: responses to oxidative stress, inflammation, and G protein-coupled receptor agonists. Molecular Neurobiology 2005 31 1-3 27 41 2-s2.0-24644511102 (Pubitemid 41271192)
114. Stephenson D., Rash K., Smalstig B., Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration. Glia 1999 27 2 110 128 (Pubitemid 29365748)
115. Gentile M. T., Reccia M. G., Sorrentino P. P., Role of cytosolic calcium-dependent phospholipase A2 in Alzheimer's disease pathogenesis. Molecular Neurobiology 2012 45 3 596 604
116. Szaingurten-Solodkin I., Hadad N., Levy R., Regulatory role of cytosolic phospholipase A2 α in NADPH oxidase activity and in inducible nitric oxide synthase induction by aggregated A β 1-42 in microglia. Glia 2009 57 16 1727 1740 2-s2.0-71249160483 10.1002/glia.20886
117. Guo C., Li J., Myatt L., Zhu X., Sun K., Induction of G α s contributes to the paradoxical stimulation of cytosolic phospholipase A2 α expression by cortisol in human amnion fibroblasts. Molecular Endocrinology 2010 24 5 1052 1061 2-s2.0-77954848124 10.1210/me.2009-0488
118. Bazan N. G., Colangelo V., Lukiw W. J., Prostaglandins and other lipid mediators in Alzheimer's disease. Prostaglandins and Other Lipid Mediators 2002 68-69 197 210 2-s2.0-0036669582 10.1016/S0090-6980(02)00031-X (Pubitemid 35247397)
119. Williams C. S., Mann M., DuBois R. N., The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999 18 55 7908 7916 2-s2.0-0033590207 (Pubitemid 30066236)
120. Samad T. A., Moore K. A., Sapirstein A., Billet S., Allchorne A., Poole S., Bonventre J. V., Woolf C. J., Interleukin-1 β -mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001 410 6827 471 475 2-s2.0-0035932121 10.1038/35068566 (Pubitemid 32240046)
121. Tanabe T., Tohnai N., Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins and Other Lipid Mediators 2002 68-69 95 114 2-s2.0-0036669611 10.1016/S0090-6980(02)00024-2 (Pubitemid 35247390)
122. Korotkova M., Westman M., Gheorghe K. R., Af Klint E., Trollmo C., Ulfgren A. K., Klareskog L., Jakobsson P.-J., Effects of antirheumatic treatments on the prostaglandin E2 biosynthetic pathway. Arthritis and Rheumatism 2005 52 11 3439 3447 2-s2.0-27744507122 10.1002/art.21390 (Pubitemid 41612210)
123. Ejima K., Layne M. D., Carvajal I. M., Kritek P. A., Baron R. M., Chen Y.-H., Vom Saal J., Levy B. D., Yet S.-F., Perrella M. A., Cyclooxygenase-2- deficient mice are resistant to endotoxin-induced inflammation and death. The FASEB Journal 2003 17 10 1325 1327 2-s2.0-0038604366
124. Tocco G., Freire-Moar J., Schreiber S. S., Sakhi S. H., Aisen P. S., Pasinetti G. M., Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease. Experimental Neurology 1997 144 2 339 349 2-s2.0-0031127741 10.1006/exnr.1997. 6429 (Pubitemid 27224561)
125. Tung W.-H., Lee I.-T., Hsieh H.-L., Yang C.-M., EV71 induces COX-2 expression via c-Src/PDGFR/PI3K/Akt/p42/p44 MAPK/AP-1 and NF- B in rat brain astrocytes. Journal of Cellular Physiology 2010 224 2 376 386 2-s2.0-77953644816 10.1002/jcp.22133
126. Tung W.-H., Hsieh H.-L., Lee I.-T., Yang C.-M., Enterovirus 71 modulates a COX-2/PGE2/cAMP-dependent viral replication in human neuroblastoma cells: role of the c-Src/EGFR/p42/p44 MAPK/CREB signaling pathway. Journal of Cellular Biochemistry 2011 112 2 559 570 2-s2.0-79251623053 10.1002/jcb.22946
127. Hsieh H. L., Lin C. C., Chan H. J., Yang C. M., Yang C. M., c-Src-dependent EGF receptor transactivation contributes to ET-1-induced COX-2 expression in brain microvascular endothelial cells. Journal of Neuroinflammation 2012 9 152
128. Kim D. S., Kim J. Y., Han Y., Curcuminoids in neurodegenerative diseases. Recent Patents on CNS Drug Discovery 2012 7 3 184 204
129. Smith K. J., Lassmann H., The role of nitric oxide in multiple sclerosis. The Lancet Neurology 2002 1 4 232 241 2-s2.0-0013292906 10.1016/S1474-4422(02) 00102-3 (Pubitemid 37159185)
130. Barbeito L. H., Pehar M., Cassina P., Vargas M. R., Peluffo H., Viera L., Estévez A. G., Beckman J. S., A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Research Reviews 2004 47 1-3 263 274 2-s2.0-9644255989 10.1016/j.brainresrev.2004.05.003 (Pubitemid 39574324)
131. Saha R. N., Pahan K., Regulation of inducible nitric oxide synthase gene in glial cells. Antioxidants and Redox Signaling 2006 8 5-6 929 947 2-s2.0-33745807628 10.1089/ars.2006.8.929 (Pubitemid 44036510)
132. Galea E., Feinstein D. L., Reis D. J., Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. Proceedings of the National Academy of Sciences of the United States of America 1992 89 22 10945 10949 2-s2.0-0026486613 10.1073/pnas.89.22.10945
133. Parmentier-Batteur S., Bohme G. A., Lerouet D., Zhou-Ding L., Beray V., Margaill I., Plotkine M., Antisense oligodeoxynucleotide to inducible nitric oxide synthase protects against transient focal cerebral ischemia-induced brain injury. Journal of Cerebral Blood Flow and Metabolism 2001 21 1 15 21 2-s2.0-0035200650 (Pubitemid 32016835)
134. Li J., Baud O., Vartanian T., Volpe J. J., Rosenberg P. A., Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proceedings of the National Academy of Sciences of the United States of America 2005 102 28 9936 9941 2-s2.0-22244470745 10.1073/pnas.0502552102 (Pubitemid 40993671)
135. Choi S.-H., Joe E. H., Kim S. U., Jin B. K., Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo. The Journal of Neuroscience 2003 23 13 5877 5886 2-s2.0-0038383698 (Pubitemid 36807867)
136. Springer T. A., Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994 76 2 301 314 2-s2.0-0027982876 10.1016/0092-8674(94)90337-9 (Pubitemid 24046692)
137. Cook-Mills J. M., VCAM-1 signals during lymphocyte migration: role of reactive oxygen species. Molecular Immunology 2002 39 9 499 508 2-s2.0-0036889639 10.1016/S0161-5890(02)00206-7 (Pubitemid 35341488)
138. Osborn L., Hession C., Tizard R., Vassallo C., Luhowskyj S., Chi-Rosso G., Lobb R., Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989 59 6 1203 1211 2-s2.0-0024818401 10.1016/0092-8674(89)90775-7 (Pubitemid 20024630)
139. Michalska M., Machtoub L., Manthey H. D., Visualization of vascular inflammation in the atherosclerotic mouse by ultrasmall superparamagnetic iron oxide vascular cell adhesion molecule-1-specific nanoparticles. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 10 2350 2357
140. Tang C., Xue H.-L., Bai C.-L., Fu R., Regulation of adhesion molecules expression in TNF- α-stimulated brain microvascular endothelial cells by tanshinone IIA: involvement of NF- B and ROS generation. Phytotherapy Research 2011 25 3 376 380 2-s2.0-79952213321 10.1002/ptr.3278
141. Song H. Y., Ryu J., Ju S. M., Lee J. P., Ji A. L., Soo Y. C., Park J., Extracellular HIV-1 Tat enhances monocyte adhesion by up-regulation of ICAM-1 and VCAM-1 gene expression via ROS-dependent NF- B activation in astrocytes. Experimental and Molecular Medicine 2007 39 1 27 37 2-s2.0-33847677681 (Pubitemid 46356003)
142. Jacquier-Sarlin M. R., Fuller K., Dinh-Xuan A. T., Richard M.-J., Polla B. S., Protective effects of hsp70 in inflammation. Experientia 1994 50 11-12 1031 1038 2-s2.0-0028035112 10.1007/BF01923458 (Pubitemid 24369758)
143. Aridon P., Geraci F., Turturici G., D'amelio M., Savettieri G., Sconzo G., Protective role of heat shock proteins in Parkinson's disease. Neurodegenerative Diseases 2011 8 4 155 168 2-s2.0-79955830308 10.1159/000321548
144. Luo W., Sun W., Taldone T., Rodina A., Chiosis G., Heat shock protein 90 in neurodegenerative diseases. Molecular Neurodegeneration 2010 5 1, article 24 2-s2.0-77953012604 10.1186/1750-1326-5-24
145. Patury S., Miyata Y., Gestwicki J. E., Pharmacological targeting of the Hsp70 chaperone. Current Topics in Medicinal Chemistry 2009 9 15 1337 1351 2-s2.0-74249097474 10.2174/156802609789895674
146. Yamashima T., Hsp70.1 and related lysosomal factors for necrotic neuronal death. Journal of Neurochemistry 2012 120 4 477 494 2-s2.0-84855946896 10.1111/j.1471-4159.2011.07596.x
147. Kyriakis J. M., Avruch J., Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiological Reviews 2001 81 2 807 869 2-s2.0-0035066383 (Pubitemid 32267078)
148. Irving E. A., Bamford M., Role of mitogen- and stress-activated kinases in ischemic injury. Journal of Cerebral Blood Flow and Metabolism 2002 22 6 631 647 2-s2.0-0036263403 (Pubitemid 34596455)
149. Harper S. J., Lograsso P., Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38. Cellular Signalling 2001 13 5 299 310 2-s2.0-0035033952 10.1016/S0898-6568(01)00148-6 (Pubitemid 32448947)
150. Hensley K., Floyd R. A., Zheng N.-Y., Nael R., Robinson K. A., Nguyen X., Pye Q. N., Stewart C. A., Geddes J., Markesbery W. R., Patel E., Johnson G. V. W., Bing G., p38 Kinase is activated in the Alzheimer's disease brain. Journal of Neurochemistry 1999 72 5 2053 2058 2-s2.0-0033043939 10.1046/j.1471-4159. 1999.0722053.x (Pubitemid 29186010)
151. Hu J., Akama K. T., Krafft G. A., Chromy B. A., van Eldik L. J., Amyloid- β peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Research 1998 785 2 195 206 2-s2.0-0032473596 10.1016/S0006-8993(97)01318-8 (Pubitemid 28179382)
152. Deb S., Zhang J. W., Gottschall P. E., β -amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes. Brain Research 2003 970 1-2 205 213 2-s2.0-0037466395 10.1016/S0006-8993(03) 02344-8 (Pubitemid 36423196)
153. Yarden Y., Sliwkowski M. X., Untangling the ErbB signalling network. Nature Reviews Molecular Cell Biology 2001 2 2 127 137 2-s2.0-0035256698 10.1038/35052073 (Pubitemid 33674041)
154. Daub H., Weiss F. U., Wallasch C., Ullrich A., Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 1996 379 6565 557 560 2-s2.0-0030044360 10.1038/379557a0 (Pubitemid 26049585)
155. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., Ullrich A., EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999 402 6764 884 888 2-s2.0-0033599039 10.1038/47260 (Pubitemid 30017171)
156. Lee F. S., Chao M. V., Activation of Trk neurotrophin receptors in the absence of neurotrophins. Proceedings of the National Academy of Sciences of the United States of America 2001 98 6 3555 3560 2-s2.0-0035853065 10.1073/pnas.061020198 (Pubitemid 32220883)
157. Herrlich A., Daub H., Knebel A., Herrlich P., Ullrich A., Schultz G., Gudermann T., Ligand-independent activation of platelet-derived growth factor receptor is a necessary intermediate in lysophosphatidic, acid-stimulated mitogenic activity in L cells. Proceedings of the National Academy of Sciences of the United States of America 1998 95 15 8985 8990 2-s2.0-0032555202 10.1073/pnas.95.15.8985 (Pubitemid 28350601)
158. Buchanan F. G., Wang D., Bargiacchi F., DuBois R. N., Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. The Journal of Biological Chemistry 2003 278 37 35451 35457 2-s2.0-0041816104 10.1074/jbc.M302474200 (Pubitemid 37102315)
159. Tanimoto T., Jin Z.-G., Berk B. C., Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS). The Journal of Biological Chemistry 2002 277 45 42997 43001 2-s2.0-0037044854 10.1074/jbc.M204764200 (Pubitemid 35285679)
160. Neufeld G., Cohen T., Gengrinovitch S., Poltorak Z., Vascular endothelial growth factor (VEGF) and its receptors. The FASEB Journal 1999 13 1 9 22 2-s2.0-0032907687 (Pubitemid 29038270)
161. Lei H., Kazlauskas A., Growth factors outside of the platelet-derived growth factor (PDGF) family employ reactive oxygen species/Src family kinases to activate PDGF receptor α and thereby promote proliferation and survival of cells. The Journal of Biological Chemistry 2009 284 10 6329 6336 2-s2.0-65249157149 10.1074/jbc.M808426200
162. Chen K. C.-W., Zhou Y., Xing K., Krysan K., Lou M. F., Platelet derived growth factor (PDGF)-induced reactive oxygen species in the lens epithelial cells: the redox signaling. Experimental Eye Research 2004 78 6 1057 1067 2-s2.0-1942487302 10.1016/j.exer.2004.02.004 (Pubitemid 38510343)
163. Liu B., Neufeld A. H., Activation of epidermal growth factor receptors in astrocytes: from development to neural injury. Journal of Neuroscience Research 2007 85 16 3523 3529 2-s2.0-36849086033 10.1002/jnr.21364 (Pubitemid 350228697)
164. Ptasznik A., Prossnitz E. R., Yoshikawa D., Smrcka A., Traynor-Kaplan A. E., Bokoch G. M., A tyrosine kinase signaling pathway accounts for the majority of phosphatidylinositol 3,4,5-trisphosphate formation in chemoattractant- stimulated human neutrophils. The Journal of Biological Chemistry 1996 271 41 25204 25207 2-s2.0-0029823946 10.1074/jbc.271.41.25204 (Pubitemid 26337883)
165. 2 preconditioning modulates phase II enzymes through p38 MAPK and PI3K/Akt activation. American Journal of Physiology-Heart and Circulatory Physiology 2011 300 6 H2196 H2205 2-s2.0-79958033772 10.1152/ajpheart.00934.2010
166. Pan J., Chang Q., Wang X., Son Y., Zhang Z., Chen G., Luo J., Bi Y., Chen F., Shi X., Reactive oxygen species-activated Akt/ASK1/p38 signaling pathway in nickel compound-induced apoptosis in BEAS 2B cells. Chemical Research in Toxicology 2010 23 3 568 577 2-s2.0-77949363159 10.1021/tx9003193
167. Jr Baldwin A. S., The NF-kB and IkB proteins: new discoveries and insights. Annual Review of Immunology 1996 14 649 683 (Pubitemid 26130197)
168. Haddad J. J., Oxygen-sensitive pro-inflammatory cytokines, apoptosis signaling and redox-responsive transcription factors in development and pathophysiology. Cytokines, Cellular and Molecular Therapy 2002 7 1 1 14 2-s2.0-0036021828 10.1080/13684730216401 (Pubitemid 34831964)
169. Barnes P. J., Karin M., Nuclear factor- B-a pivotal transcription factor in chronic inflammatory diseases. The New England Journal of Medicine 1997 336 15 1066 1071 2-s2.0-0030615201 10.1056/NEJM199704103361506 (Pubitemid 27163860)
170. Eberhardt W., Huwiler A., Beck K.-F., Walpen S., Pfeilschifter J., Amplification of IL-1 β -induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF- B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. The Journal of Immunology 2000 165 10 5788 5797 2-s2.0-0034669989
171. Kim S. Y., Moon K.-A., Jo H.-Y., Jeong S., Seon S.-H., Jung E., Cho Y. S., Chun E., Lee K.-Y., Anti-inflammatory effects of apocynin, an inhibitor of NADPH oxidase, in airway inflammation. Immunology and Cell Biology 2012 90 4 441 448 2-s2.0-84859953055 10.1038/icb.2011.60
172. Cheng S.-E., Lin C.-C., Lee I.-T., Hsu C.-K., Kou Y. R., Yang C.-M., Cigarette smoke extract regulates cytosolic phospholipase A2 expression via NADPH oxidase/MAPKs/AP-1 and p300 in human tracheal smooth muscle cells. Journal of Cellular Biochemistry 2011 112 2 589 599 2-s2.0-79251616588 10.1002/jcb.22949
173. Chan H. M., La Thangue N. B., p300/CBP proteins: HATs for transcriptional bridges and scaffolds. Journal of Cell Science 2001 114 13 2363 2373 2-s2.0-0034916613 (Pubitemid 32684792)
174. Asahara H., Tartare-Deckert S., Nakagawa T., Ikehara T., Hirose F., Hunter T., Ito T., Montminy M., Dual roles of p300 in chromatin assembly and transcriptional activation in cooperation with nucleosome assembly protein 1 in vitro. Molecular and Cellular Biology 2002 22 9 2974 2983 2-s2.0-0036236469 10.1128/MCB.22.9.2974-2983.2002 (Pubitemid 34437456)
175. Ma H., Nguyen C., Lee K.-S., Kahn M., Differential roles for the coactivators CBP and p300 on TCF/ β -catenin-mediated survivin gene expression. Oncogene 2005 24 22 3619 3631 2-s2.0-19944422429 10.1038/sj.onc.1208433 (Pubitemid 40756231)